150 related articles for article (PubMed ID: 34060234)
1. Identification of 1,2,4-Triazolylthioethanone Scaffold for the Design of New Acetylcholinesterase Inhibitors.
Fatiha Muhammad E; Kumar A; Wahab HA; Zhang KYJ
Mol Inform; 2021 Aug; 40(8):e2100020. PubMed ID: 34060234
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
Ambure P; Kar S; Roy K
Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
[TBL] [Abstract][Full Text] [Related]
4. Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches.
Mokrani EH; Bensegueni A; Chaput L; Beauvineau C; Djeghim H; Mouawad L
Mol Inform; 2019 May; 38(5):e1800118. PubMed ID: 30725535
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation.
Jiang CS; Ge YX; Cheng ZQ; Song JL; Wang YY; Zhu K; Zhang H
J Comput Aided Mol Des; 2019 May; 33(5):521-530. PubMed ID: 30989573
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Biological Evaluation of New Selective Acetylcholinesterase Inhibitors with Anti-Aβ Aggregation Activity through Molecular Docking-Based Virtual Screening.
Liu G; Jiao Y; Lin Y; Hao H; Dou Y; Yang J; Jiang CS; Chang P
Chem Pharm Bull (Tokyo); 2020 Feb; 68(2):161-166. PubMed ID: 31813907
[TBL] [Abstract][Full Text] [Related]
7. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
Dhanjal JK; Sharma S; Grover A; Das A
Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
9. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
10. The impact of some phenolic compounds on serum acetylcholinesterase: kinetic analysis of an enzyme/inhibitor interaction and molecular docking study.
Işık M; Beydemir Ş
J Biomol Struct Dyn; 2021 Oct; 39(17):6515-6523. PubMed ID: 32746727
[TBL] [Abstract][Full Text] [Related]
11. Combined Structure and Ligand-Based Design of Selective Acetylcholinesterase Inhibitors.
Pérez-Sánchez H; den Haan H; Pérez-Garrido A; Peña-García J; Chakraborty S; Erdogan Orhan I; Senol Deniz FS; Villalgordo JM
J Chem Inf Model; 2021 Jan; 61(1):467-480. PubMed ID: 33320652
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease.
de Almeida JR; Figueiro M; Almeida WP; de Paula da Silva CHT
Future Med Chem; 2018 May; 10(9):1037-1053. PubMed ID: 29676170
[TBL] [Abstract][Full Text] [Related]
13. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
14. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
15. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
16. Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.
Yang H; Du C; Li Q; Chen T; Lu X; Li Q; Feng F; Chen Y; Liu W; Sun H
Bioorg Chem; 2019 Nov; 92():103294. PubMed ID: 31557623
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.
Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD
Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease.
Hu J; Huang YD; Pan T; Zhang T; Su T; Li X; Luo HB; Huang L
ACS Chem Neurosci; 2019 Jan; 10(1):537-551. PubMed ID: 30252439
[TBL] [Abstract][Full Text] [Related]
20. Virtual Screening and Hit Selection of Natural Compounds as Acetylcholinesterase Inhibitors.
Atanasova M; Dimitrov I; Ivanov S; Georgiev B; Berkov S; Zheleva-Dimitrova D; Doytchinova I
Molecules; 2022 May; 27(10):. PubMed ID: 35630613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
